Skip to main content
. 2014 Jun 6;8:701–717. doi: 10.2147/DDDT.S59679

Figure 1.

Figure 1

Molecular design and development of biguanide derivatives for anticancer agents targeting TME. (A) Structures of antidiabetic biguanides. (B) Molecular design of biguanide derivatives.

Note: The bolded numbers identify a specific compound.

Abbreviation: TME, tumor microenvironment.